Newamsterdam Pharma Company N.V. (($NAMS)) announced an update on their ongoing clinical study. Study Overview: NewAmsterdam Pharma is conducting ...
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered ...
The tiny blood vessels in your eyes might hold the key to predicting a person's risk of developing heart disease and how fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback